These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of congestive heart failure on quinidine pharmacokinetics. Crouthamel WG Am Heart J; 1975 Sep; 90(3):335-9. PubMed ID: 1163425 [TBL] [Abstract][Full Text] [Related]
5. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution. Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686 [TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of quinidine gluconate and quinidine sulfate in healthy volunteers. Covinsky JO; Russo J; Kelly KL; Cashman J; Amick EN; Mason WD J Clin Pharmacol; 1979; 19(5-6):261-9. PubMed ID: 469022 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies of quinidine in patients with arrhythmias. Conrad KA; Molk BL; Chidsey CA Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196 [TBL] [Abstract][Full Text] [Related]
11. Absolute bioavailability of quinidine in two sustained release preparations. Amlie JP; Storstein L; Olsson B; Fremstad D; Jacobsen S Eur J Clin Pharmacol; 1979 Aug; 16(1):45-8. PubMed ID: 499299 [TBL] [Abstract][Full Text] [Related]
12. The bioavailability and kinetics of dihydroquinidine in patients with heart disease. Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability of 11 quinidine formulations adn pharmacokinetic variation in humans. McGilveray IJ; Midha KK; Rowe M; Beaudoin N; Charette C J Pharm Sci; 1981 May; 70(5):524-9. PubMed ID: 7241357 [TBL] [Abstract][Full Text] [Related]
14. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state. St-Onge JM; Sirois G; Gagnon MA Eur J Drug Metab Pharmacokinet; 1983; 8(4):363-72. PubMed ID: 6673973 [TBL] [Abstract][Full Text] [Related]
15. Effect of caffeine on the oral absorption and disposition of quinidine. Zeller FP; Ueda CT; Wulf BG; Meyers DG Clin Pharm; 1984; 3(1):72-5. PubMed ID: 6697677 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of furosemide in patients with congestive heart failure. Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of prazosin. Jaillon P Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981 [TBL] [Abstract][Full Text] [Related]
18. Absorption of quinidine from an enteric-coated preparation. Fremstad D; Nilsen OG; Amlie J; Storstein L; Olsson B; Jacobsen S Eur J Clin Pharmacol; 1979 Sep; 16(2):107-12. PubMed ID: 499306 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of quinidine. Fattinger K; Vozeh S; Ha HR; Borner M; Follath F Br J Clin Pharmacol; 1991 Mar; 31(3):279-86. PubMed ID: 2054269 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses. McGuirk SM; Muir WW; Sams RA Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]